维普中文期刊产品整合服务
385篇 您的检索式:作者名="FOUAD A A"
    题名 作者 年代 出处 被引量
1Trends and outcomes of pancreaticoduodenectomy for periampullary tumors: A 25-year single-center study of 1000 consecutive cases显示文摘AIM To evaluate the evolution, trends in surgical approaches a n d r e c o n s t r u c t i o n t e c h n i q u e s, a n d i m p o r t a n t lessons learned from performing 1000 consecutive pancreaticoduodenectomies(PDs) for periampullary tumors.METHODS This is a retrospective review of the data of all patients who underwent PD for periampullary tumor during the period from January 1993 to April 2017. The data were categorized into three periods, including early period(1993-2002), middle period(2003-2012), and late period(2013-2017).RESULTS The frequency showed PD was increasingly performed after the year 2000. With time, elderly, cirrhotic and obese patients, as well as patients with uncinate process carcinoma and borderline tumor were increasingly selected for PD. The median operative time and postoperative hospital stay decreased significantly over the periods. Hospital mortality declined significantly, from 6.6% to 3.1%. Postoperative complications significantly decreased, from 40% to 27.9%. There was significant decrease in postoperative pancreatic fistula in the second 10 years, from 15% to 12.7%. There was a significant improvement in median survival and overall survival among the periods.CONCLUSION Surgical results of PD significantly improved, with mortality rate nearly reaching 3%. Pancreatic reconstruction following PD is still debatable. The survival rate was also improved but the rate of recurrence is still high, at 36.9%.ayman el nakeeb waleed askar ehab atef ehab el hanafy ahmad m sultan tarek salah ahmed shehta mohamed el sorogy emad hamdy mohamed el hemly ahmed a el-geidi tharwat kandil mohamed el shobari talaat abd allah amgad fouad mostafa abu zeid ahmed abu el eneen nabil gad el-hak gamal el ebidy omar fathy ahmed sultan mohamed abdel wahab 2017World Journal of Gastroenterology2017,23,38:15
2Early therapeutic effect of platelet-rich fibrin combined with allogeneic bone marrow-derived stem cells on rats’ critical-sized mandibular defects显示文摘BACKGROUND Critically sized bone defects represent a significant challenge to orthopaedic surgeons worldwide.These defects generally result from severe trauma or resection of a whole large tumour.Autologous bone grafts are the current gold standard for the reconstruction of such defects.However,due to increased patient morbidity and the need for a second operative site,other lines of treatment should be introduced.To find alternative unconventional therapies to manage such defects,bone tissue engineering using a combination of suitable bioactive factors,cells,and biocompatible scaffolds offers a promising new approach for bone regeneration.AIM To evaluate the healing capacity of platelet-rich fibrin(PRF)membranes seeded with allogeneic mesenchymal bone marrow-derived stem cells(BMSCs)on critically sized mandibular defects in a rat model.METHODS Sixty-three Sprague Dawley rats were subjected to bilateral bone defects of critical size in the mandibles created by a 5-mm diameter trephine bur.Rats were allocated to three equal groups of 21 rats each.Group I bone defects were irrigated with normal saline and designed as negative controls.Defects of group II were grafted with PRF membranes and served as positive controls,while defects of group III were grafted with PRF membranes seeded with allogeneic BMSCs.Seven rats from each group were killed at 1,2 and 4 wk.The mandibles were dissected and prepared for routine haematoxylin and eosin(HE)staining,Masson's trichrome staining and CD68 immunohistochemical staining.RESULTS Four weeks postoperatively,the percentage area of newly formed bone was significantly higher in group III(0.88±0.02)than in groups I(0.02±0.00)and II(0.60±0.02).The amount of granulation tissue formation was lower in group III(0.12±0.02)than in groups I(0.20±0.02)and II(0.40±0.02).The number of inflammatory cells was lower in group III(0.29±0.03)than in groups I(4.82±0.08)and II(3.09±0.07).CONCLUSION Bone regenerative quality of critically sized mandibular bone defects in rats was better promoted by PRF membranes seeded with BMSCs than with PRF membranes alone.Muhammad A Awadeen Fouad A Al-Belasy Laila E Ameen Mohamad E Helal Mohammed E Grawish 2020World Journal of Stem Cells2020,12,1:4
3Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: Binding and entry显示文摘AIM: We designed two synthetic-core-specific peptides core 1 (C1) and core 2 (C2), and an E1-specific peptide (E1). We produced specific polyclonal antibodies againstthese peptides and used the antibodies for detection of HCV antigens on surface and within infected peripheral blood leukocytes.METHODS: Peripheral blood from a healthy individual who tested negative for HCV RNA was incubated with HCV type 4 infected serum for 1 h and 24 h at 37 ℃. Cells were stained by direct and indirect immunofluorescence and measured by flow cytometry.RESULTS: After 1 h of incubation, antibodies against C1,C2, and E1 detected HCV antigens on the surface of 27%,26% and 73% of monocytes respectively, while 10%, 5% and 9% of lymphocytes were positive with anti-C1, anti-C2 and anti-E1 respectively. Only 1-3% of granulocytes showed positive staining with anti-C1, anti-C2 and anti E1 antibodies. After 24 h of incubation, we found no surface staining with anti-C1, anti-C2 or anti-E1. Direct immunostaining using anti-C2 could not detect intracellular HCV antigens, after 1 h of incubation with the virus, while after 24 h of incubation, 28% of infected cells showed positive staining. Only plus strand RNA was detectable intracellularly as early as 1 h after incubation, and remained detectable throughout 48 h post-infection.Interestingly, minus RNA strand could not be detected after 1 h, but became strongly detectable intracellularly after 24 h post-infection.CONCLUSION: Monocytes and lymphocytes are the preferred target cells for HCV infection in peripheral blood leukocytes. Our specific anti-core and anti-E1 antibodies are valuable reagents for demonstration of HCV cell cycle.Also, HCV is capable of infecting and replicating in peripheral blood mononuclear cells as confirmed by detection of minus strand HCV RNA as well as intracellular staining of core HCV antigen.Mostafa K El-Awady Ashraf A Tabll El-Rashdy M Redwan Samar Youssef Moataza H Omran Fouad Thakeb Maha El-Demellawy 2005World Journal of Gastroenterology2005,11,33:4
4Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice显示文摘AIM:To study the possible interactions of metoclopramide,domperidone and erythromycin in streptozotocin-induced diabetic mice treated with insulin by various parameters.METHODS:Effects of the individual as well as combined drugs were studied in diabetic mice via estimation of the blood glucose and serum insulin levels,small intestinal transit(SIT),gastric emptying(GE),xylose absorption and glucose tolerance tests.Groups were given insulin 2 IU/kg s.c.,metoclopramide 20 mg/kg p.o.,domperidone 20 mg/kg p.o.and erythromycin 6 mg/kg p.o.individually and in combination.There were also normal and diabetic control groups.The first set of experiments was carried out to investigate the subchronic effect on blood glucose and serum insulin levels in diabetic mice of one week of daily dose administration of the tested drugs individually as well as the combination of insulin with each prokinetic drug.The other five sets of experiments were carried out to investigate the acute effect of a single dose of each drug individually and in combination on blood glucose and serum insulin levels,SIT,GE,oral xylose absorption and glucose tolerance tests.RESULTS:The study included the prokinetic drugs metoclopramide(20 mg/kg),domperidone(20 mg/kg) and erythromycin(6 mg/kg),as well as insulin(2 IU/kg),which was individually effective in decreasing SIT,enhancing GE and increasing xylose absorption significantly in diabetic mice.Erythromycin tended to decrease blood glucose level and increase serum insulin level after 1 wk of daily administration in diabetic mice.Erythromycin potentiated the effect of insulin on blood glucose level and serum insulin level whereas other prokinetic agents failed to do so after repeated dose administration in diabetic mice.Metoclopramide or erythromycin in combination with insulin significantly decreased SIT,in diabetic mice,to lower levels than with insulin alone.Administration of prokinetic drugs along with insulin antagonized the action of insulin on xylose absorption.These combinations also increased the rate of glucose absorption from the gut.CONCLUSION:The present study suggests that prokinetic drugs could potentially improve glycemic control in diabetic gastroparesis by allowing a more predictable absorption of nutrients,matched to the action of exogenous insulin.The use of prokinetics,such as erythromycin,may be interesting in the clinic in decreasing the need for insulin in diabetic patients.The dose of insulin may be safely decreased with erythromycin in chronic treatments.Mohamed A Fouad Shalaby Hekma A Abd El Latif Mostafa E El Sayed 2013World Journal of Gastrointestinal Pharmacology and Therapeutics2013,4,2:3
5饲粮叶酸添加水平对山麻鸭产蛋性能、蛋品质、生殖器官及血浆生殖激素指标的影响显示文摘本试验旨在研究饲粮叶酸(FA)添加水平对山麻鸭产蛋性能、蛋品质、生殖器官及血浆生殖激素指标的影响,以确定产蛋期(18~32周龄)山麻鸭FA的需要量。试验选用16周龄的山麻鸭360只,随机分成6个组,每个组5个重复,每个重复12只,单笼饲养。试验蛋鸭饲喂不添加FA的基础饲粮2周后,分别饲喂在基础饲粮中添加0、0.5、1.0、2.0、4.0、8.0 mg/kg FA的试验饲粮,试验期15周。结果表明:1)饲粮FA添加水平对产蛋初期、产蛋高峰期和试验全期的蛋鸭产蛋性能指标无显著影响(P〉0.05)。2)随着饲粮FA添加水平的提高,蛋壳相对重和蛋壳厚度先升高后下降,1.0 mg/kg FA添加组的蛋壳相对重显著高于其他组(P〈0.05)。3)随着饲粮FA添加水平的提高,优势卵泡重、优势卵泡重/卵巢重先升高后降低,饲粮FA添加水平对优势卵泡重和优势卵泡重/卵巢重有显著影响(P〈0.05),以4.0mg/kg FA添加组最高。4)随着饲粮FA添加水平的提高,血浆孕酮浓度先升高后下降,其中2.0 mg/kg FA添加组血浆孕酮浓度最高;8.0 mg/kg FA添加组血浆促黄体生成素浓度显著高于其他各组(P〈0.05)。由此可见,在玉米-豆粕型饲粮中添加FA在一定程度上有利于促进优势卵泡的发育,但未能显著影响山麻鸭的产蛋性能。仅考虑产蛋性能,玉米-豆粕型饲粮中不需添加FA;以蛋壳相对重和蛋壳厚度为评价指标,建议玉米-豆粕型饲粮FA适宜添加水平为1.0 mg/kg。夏伟光 王胜林 陈伟 阮栋 王爽 FOUAD A M 林映才 郑春田 2016动物营养学报2016,28,7:3
6Towards hepatitis C virus elimination:Egyptian experience,achievements and limitations显示文摘Worldwide, more than one million people die each year from hepatitis C virus(HCV) related diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt used to be on the top of the countries with heavy HCV burden. Some countries are making advances in elimination of HCV, yet multiple factors preventing progress; remain for the majority. These factors include lack of global funding sources for treatment, late diagnosis, poor data, and inadequate screening. Treatment of HCV in Egypt has become one of the top national priorities since 2007. Egypt started a national treatment program intending to provide cure for Egyptian HCV-infected patients. Mass HCV treatment program had started using Pegylated interferon and ribavirin between 2007 and 2014. Yet, with the development of highly-effective direct acting antivirals(DAAs) for HCV, elimination of viral hepatitis has become a real possibility. The Egyptian National Committee for the Control of Viral Hepatitis did its best to provide Egyptian HCV patients with DAAs. Egypt adopted a strategy that represents a model of care that could help other countries with high HCV prevalence rate in their battle against HCV. This review covers the effects of HCV management in Egyptian real life settings and the outcome of different treatment protocols. Also, it deals with the current and future strategies for HCV prevention and screening as well as the challenges facing HCV elimination and the prospect of future eradication of HCV.Dalia Omran Mohamed Alboraie Rania A Zayed Mohamed-Naguib Wifi Mervat Naguib Mohamed Eltabbakh Mohamed Abdellah Ahmed Fouad Sherief Sahar Maklad Heba Hamdy Eldemellawy Omar Khalid Saad Doaa Mohamed Khamiss Mohamed El Kassas 2018World Journal of Gastroenterology2018,24,38:2
7Surface to bulk characterization of phosphate modified aluminas显示文摘Mekhemer G A H Nohman A K H Fouad N E 2000Colloids and Surfaces A Physicochemical and Engineering Aspects2000,161,3:1
8System vulnerability as a concept to assess power system dynamic security显示文摘Fouad A A Qin Zhou Vittal V 1994IEEE Trans on Power Systems1994,9,2:1
9Energy consumption and costs with a multi-stage flashing (MSF)desalting system显示文摘M A Darwish Fouad A Yousef N M AI Najem 1997Desalination1997,109,1:1
10Endodontic interappointment flare-ups:prospec-tive study of incidence and related factors显示文摘Walton R Fouad A 1992J Endod1992,18,4:1
11Fast packet switch architectures for broadband integrated services digital networks 显示文摘Tobagi Fouad A 1990Proceedings of the IEEE1990,78,1:1
12Influence of cuslallization times on the synthesis of nanosized ZSM - 5 显示文摘Mohamed R M Fouad O A Ismail A A 2005Mater Lett2005,59,:1
13Endodontic interappointment fiare-ups:a prospective study of incidence and rwiated factors 显示文摘Walton R Fouad A 1992J Endod1992,18,14:1
14Fluid prediction from 3 D seismic data in deep-water sandstone reservoirs, Veracruz Basin, southeastern Me'xico显示文摘Fouad K Jennette D C Soto-Cuervo A 2002Gulf Coast Association of Geological Societies Transactions2002,52,:1
15Letro- zole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the pe- riod of infertility, the body mass index, or the luteinizing hor- mone/folliele-stimulating hormone ratio 显示文摘ELNASHAR A FOUAD H ELDOSOKY M 2006Fertil Steril2006,85,2:1
16Endodontic interappointment flare-ups: a prospective study of incidence and relatedfactors显示文摘Walton R Fouad A 1992J Endod1992,18,4:1
17Stability Boundary Approximation of a Power Sustem Using the Real Normal Form of Vector Fields显示文摘Saha S Fouad A A Kliemann W H 1997IEEE Trans on Power Systems1997,12,2:1
18Endodonfic intemppointment flare--ups: Aprospective study of incidence and related factors 显示文摘Walton R Fouad A 1992J Endod1992,18,4:1
19System vulnerability as a concept to assess power system dynamic security显示文摘FOUAD A A ZHOU Qin VITTAL V 1994IEEE Transactions on Power Systems1994,9,2:1
20Role of transforming growth factor- 11 in serum and -509 C>T promoter gene polymor- phism in development of liver cirrhosis in Egyptian pa- tients 显示文摘Mohy A Fouad A 2014Meta Gene2014,9,2:1
返回顶部 每页显示:
共20页 首页 上一页 第1页 下一页 末页 /20 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费